Wegovy’s New Pill Form: A Major Shift in Weight-Loss Treatment

Wegovy has already changed how doctors treat obesity with a once-weekly injection. Now, it’s entering a whole new phase. Wegovy has become the first daily oral GLP-1 pill approved for chronic weight management. The FDA approved the oral tablet on December 22, 2025, giving patients a pill option alongside the existing injection. This is a big shift for people who want the benefits of GLP-1 therapy but prefer not to use injections. Let’s break down what this new Wegovy pill is, how it works, and what it means for patients.